Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Study finds GLP-1 drug cut migraine frequency by nearly half
Health and Wellness

Study finds GLP-1 drug cut migraine frequency by nearly half

Last updated: June 20, 2025 3:27 pm
Share
Study finds GLP-1 drug cut migraine frequency by nearly half
SHARE

GLP-1 drugs have long been known for their effectiveness in treating diabetes and obesity. However, a recent study presented at the European Academy of Neurology congress suggests that these drugs may have another surprising benefit – reducing migraine frequency.

The pilot study, which can be found in the journal article published on PubMed, showed that GLP-1 agonists were able to decrease monthly migraine days by nearly half. The researchers behind the study speculated that the mechanism behind this reduction in migraine frequency could be linked to the drugs’ ability to lower intracranial pressure.

Dr. Alexandra Sinclair, a neurology expert from the University of Birmingham, praised the study for its significance and the questions it raises about the potential mechanisms of action of GLP-1 agonists. While she was not directly involved in the study, Dr. Sinclair has previously conducted research on the role of these drugs in reducing intracranial pressure.

This groundbreaking research opens up new possibilities for the use of GLP-1 drugs in treating migraines, a condition that affects millions of people worldwide. By targeting intracranial pressure, these drugs may offer a novel approach to managing migraine symptoms and improving the quality of life for migraine sufferers.

While the study’s findings are promising, further research is needed to fully understand the relationship between GLP-1 agonists and migraine frequency. Nevertheless, this study represents a significant step forward in our understanding of the potential therapeutic applications of these drugs beyond diabetes and obesity.

For more in-depth analysis and exclusive content, you can subscribe to STAT+ to access premium articles, newsletters, events, and news alerts. Subscribe now to stay updated on the latest developments in medical research and healthcare.

See also  President Donald Trump — Will He Become The Drug Price Equalizer?
TAGGED:cutDrugfindsfrequencyGLP1MigraineStudy
Share This Article
Twitter Email Copy Link Print
Previous Article Sherri Papini, Convicted In 2016 Kidnapping Hoax, Again Claims She Was Kidnapped Sherri Papini, Convicted In 2016 Kidnapping Hoax, Again Claims She Was Kidnapped
Next Article Mira Murati’s Thinking Machines Lab closes on B at B valuation Mira Murati’s Thinking Machines Lab closes on $2B at $10B valuation
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

‘Bachelor’s Melissa Rycroft Told Cops She Was Hit Before DWI Arrest, Police Allege

'The Bachelor' Star Melissa Rycroft Claimed She Was Hit-and-Run Victim During Arrest, According to Authorities…

October 3, 2025

Israeli restaurateur quits controversial Gaza food group after criticism : NPR

Israeli entrepreneur Shahar Segal, known for running popular restaurants worldwide, has stepped down as a…

July 15, 2025

Heir to British pie fortune charged with killing best friend tried to break into Buckingham Palace month before murder

The British heir to the $292 million “Peter’s Pies” empire, Dylan Thomas, made headlines after…

November 14, 2024

Gaumont’s TV Units Find Winning Formula By Staying True to French DNA

The evolution of France's audiovisual sector has been a journey filled with challenges and opportunities,…

May 7, 2025

Netflix’s ‘Victoria Beckham’ Docuseries Is a Thoughtful Portrait of a Woman Reclaiming Her Image: TV Review

In today’s celebrity-driven culture, the spotlight can often be harsh and unyielding. Society seems to…

October 8, 2025

You Might Also Like

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
IVF research, FDA vouchers, dementia: Morning Rounds
Health and Wellness

IVF research, FDA vouchers, dementia: Morning Rounds

October 31, 2025
Nearly 1 in 5 urinary tract infections linked to contaminated meat
Health and Wellness

Nearly 1 in 5 urinary tract infections linked to contaminated meat

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?